Circulating tumor cells in murine myeloma

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Subcutaneous ADJ-PC5 myeloma in BALB/c mice presents hematologic abnormalities.
• These findings suggest a preleukemic syndrome characterized by thrombocytopenia, anemia, leukocytosis, and megakaryocytic hyperplasia.

Purpose of the Study:

• To investigate the homing and behavior of ADJ-PC5 myeloma cells in the spleen.
• To understand the spleen's role in modulating myeloma cell growth and dissemination.

Main Methods:

• Subcutaneous transplantation of ADJ-PC5 myeloma fragments or cell suspensions into BALB/c mice.
• Analysis of spleen tissue via light microscopy and radioimmunoassay to confirm tumor cell presence and immunoglobulin specificity.
• Detection of tumorigenic cells in peripheral circulation using indirect immunofluorescence and autoradiography.

Main Results:

• Successful transplantation of ADJ-PC5 myeloma via spleen fragments/cells, confirmed by immunoglobulin idiotype specificity.
• Tumorigenic cells were detectable in the spleen as early as 8 days post-transplantation.
• The spleen microenvironment demonstrated an ability to suppress or destroy a limited number of migrated myeloma cells.
• Circulating tumorigenic cells constituted 2-3% of leukocytes but exhibited reduced antigen expression and low proliferation rates.

Conclusions:

• The spleen microenvironment plays a critical role in controlling the early dissemination and growth of ADJ-PC5 myeloma cells.
• The observed hematologic changes in tumor-bearing mice are indicative of a preleukemic state.
• Further research into spleen-mediated immune responses could offer therapeutic strategies for myeloma.